Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Chỉ hiển thị Multimedia

First-line ipilimumab plus nivolumab delivers benefits in metastatic renal cell carcinoma
22 Dec 2023
bởiStephen Padilla
First-line combination immuno-oncology therapy (IO) with ipilimumab and nivolumab provides beneficial effects and has an acceptable safety profile in patients with metastatic renal cell carcinoma, as shown in a Japan study presented at ESMO Asia 2023.
First-line ipilimumab plus nivolumab delivers benefits in metastatic renal cell carcinoma
22 Dec 2023
Faecal microbiota spores deliver benefit in older patients with C. diff recurrence
22 Dec 2023
bởiAudrey Abella
In an integrated analysis of two phase III ECOSPOR trials presented at AIBD 2023, faecal microbiota spores (ie, live-brpk) demonstrated favourable safety and efficacy signals for the treatment of recurrent Clostridioides (C.) difficile infection (CDI) in older individuals.
Faecal microbiota spores deliver benefit in older patients with C. diff recurrence
22 Dec 2023
Abiraterone plus prednisolone, enzalutamide a toss-up in castration-resistant prostate cancer
21 Dec 2023
bởiJairia Dela Cruz
The combination of abiraterone plus prednisolone appears to have similar efficacy and safety as enzalutamide in the treatment of patients with nonmetastatic castration-resistant prostate cancer, according to a study.






